3.32% -0.07

アフターアワーズ： 2.08 0.04 +1.96%

BioStem Technologies, Inc. Common Stock (BSEM)

概要ニュース株価時系列 Financials ディスカッション予測株式分割

BioStem Technologies, Inc. Common Stock (BSEM) 最新ニュース

Oct 01, 2026

BioStem Technologies Completes $3 Million Private Placement Financing - The Globe and Mail

Oct 01, 2026

Sep 30, 2026

BioStem Technologies Completes $3 Million Private Stock and Warrants Offering - Kalkine Media

Sep 30, 2026

BioStem Technologies Secures $3 Million Private Placement; Issues Stock at $4.08 and Warrants - TradingView

Sep 30, 2026

BioStem Technologies raises $3M in private placement By Investing.com - Investing.com South Africa

Sep 30, 2026

BioStem Technologies raises $3M in private placement - Investing.com

Sep 30, 2026

BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewswire

Sep 30, 2026

Sep 21, 2026

BioStem (BSEM) lines up $40M in potential stock sales—how much has it tapped? - Stock Titan

Sep 21, 2026

Sep 18, 2026

BioStem Technologies Establishes $40 Million Committed Equity Facility With Roth Principal Investments - TradingView

Sep 18, 2026

New stock sale deal could fund BioStem (NASDAQ: BSEM) for up to three years - Stock Titan

Sep 18, 2026

BioStem Technologies Secures Access to $40 Million Equity Facility - citybiz

Sep 18, 2026

BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility - GlobeNewswire

Sep 18, 2026

BioStem (NASDAQ: BSEM) lines up $40M stock deal that could dilute investors - Stock Titan

Sep 18, 2026

Up to $40 million in shares could be sold by BioStem. It does not have to use the facility. - Stock Titan

Sep 18, 2026

Sep 17, 2026

BioStem Technologies (BSEM) CAO increases direct holdings with RSU share conversion - Stock Titan

Sep 17, 2026

BioStem Technologies (BSEM) director now holds 33,928 shares after RSU exercise - Stock Titan

Sep 17, 2026

BioStem Technologies (BSEM) CEO receives 25K shares via RSUs - Stock Titan

Sep 17, 2026

BioStem Technologies (BSEM) CFO lifts direct stake to 58,062 shares - Stock Titan

Sep 17, 2026

BioStem Technologies (BSEM) insider adds 17,196 shares at $0 - Stock Titan

Sep 17, 2026

Sep 11, 2026

BioStem Technologies (BSEM) CCO adds 500 shares through equity award - Stock Titan

Sep 11, 2026

Aug 28, 2026

BioStem Technologies (BSEM) director gains 7,671 shares - Stock Titan

Aug 28, 2026

Aug 12, 2026

BioStem Technologies Reports Second Quarter 2026 Financial Results - GlobeNewswire

Aug 12, 2026

Aug 11, 2026

BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission - Yahoo Finance

Jul 10, 2026

PHAT

$7.50

1.35%

ZVRA

$10.27

0.39%

SLDB

$5.74

5.03%

NVCT

$18.93

5.17%

CLYM

$10.91

6.03%

WVE

$3.19

3.24%

BioStem Technologies, Inc. Common Stock (BSEM)

BioStem Technologies, Inc. Common Stock (BSEM) 最新ニュース

BioStem Technologies Completes $3 Million Private Placement Financing - The Globe and Mail

BioStem Technologies Completes $3 Million Private Stock and Warrants Offering - Kalkine Media

BioStem Technologies Secures $3 Million Private Placement; Issues Stock at $4.08 and Warrants - TradingView

BioStem Technologies raises $3M in private placement By Investing.com - Investing.com South Africa

BioStem Technologies raises $3M in private placement - Investing.com

BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewswire

BioStem (BSEM) lines up $40M in potential stock sales—how much has it tapped? - Stock Titan

BioStem Technologies Establishes $40 Million Committed Equity Facility With Roth Principal Investments - TradingView

New stock sale deal could fund BioStem (NASDAQ: BSEM) for up to three years - Stock Titan

BioStem Technologies Secures Access to $40 Million Equity Facility - citybiz

BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility - GlobeNewswire

BioStem (NASDAQ: BSEM) lines up $40M stock deal that could dilute investors - Stock Titan

Up to $40 million in shares could be sold by BioStem. It does not have to use the facility. - Stock Titan

BioStem Technologies (BSEM) CAO increases direct holdings with RSU share conversion - Stock Titan

BioStem Technologies (BSEM) director now holds 33,928 shares after RSU exercise - Stock Titan

BioStem Technologies (BSEM) CEO receives 25K shares via RSUs - Stock Titan

BioStem Technologies (BSEM) CFO lifts direct stake to 58,062 shares - Stock Titan

BioStem Technologies (BSEM) insider adds 17,196 shares at $0 - Stock Titan

BioStem Technologies (BSEM) CCO adds 500 shares through equity award - Stock Titan

BioStem Technologies (BSEM) director gains 7,671 shares - Stock Titan

BioStem Technologies Reports Second Quarter 2026 Financial Results - GlobeNewswire

BioStem Technologies wins Nasdaq approval, begins trading August 7 - Dealroom

BioStem Technologies (Nasdaq:BSEM)Stock Analysis - Simply Wall Street

BioStem Technologies, Inc. (BSEM) Company Information - Simply Wall Street

BioStem Technologies Uplists to Nasdaq Capital Market - The Globe and Mail

symbol__ Stock Quote Price and Forecast - CNN

BioStem Technologies Uplists to Nasdaq Capital Market - TipRanks

BioStem Technologies Announces Nasdaq Uplisting - GlobeNewswire

BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission - Yahoo Finance

BSEMに似た銘柄